NLRP3 and diabetic kidney disease: In this review, we focus on the mechanisms by which AS-IV improves DKD by regulating NLRP3 inflammasome activation, including anti-inflammatory, antioxidative stress, reducing endoplasmic reticulum stress (ERS), regulating lipid metabolism disorders, and reducing pyroptosis.